Biogen Pharmachem (BIOGEN) | Stock Overview & Key Data

Biogen Pharmachem Industries Inc. | Small-cap | Financial Services

₹0.91

-1.09%

Biogen Pharmachem vs Motilal Oswal Biogen Pharmachem vs Authum Investment Biogen Pharmachem vs Share India Biogen Pharmachem vs Shalimar Agencies Biogen Pharmachem vs Monarch Networth Biogen Pharmachem vs NIFTY 50 | Market

Chart Range Statistics Financials Returns Ownership Calculator FAQ

Biogen Pharmachem Performance Comparison

Loading chart data...

Performance Summary

Interactive charts require JavaScript. Here's the essential performance data:

Period	Biogen Pharmachem	Financial Services Sector	NIFTY 50
1 Week	3.41%	N/A	N/A
1 Month	-2.15%	N/A	N/A
3 Months	-10.78%	N/A	N/A
6 Months	-11.65%	N/A	N/A
1 Year	-31.06%	N/A	N/A
3 Years	-3.19%	N/A	N/A
5 Years	127.50%	N/A	N/A

Stock Range

Today's Range

Low: ₹0.91 High: ₹0.93

on August 22, 2025

52 Week Range

Low: ₹0.75 High: ₹1.45

on May 9, 2025

on August 29, 2024

All-Time High: ₹1.85 on March 14, 2022

Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights

Key Statistics

Market Cap i INR830.4M

EPS i 0.01

P/E Ratio (TTM) i 92.00

Forward P/E i N/A

P/B Ratio i 0.59

PEG Ratio i -0.18

Div. Yield i N/A

ROE i -0.32%

Beta i -0.739

Debt to Equity i 0.00

Financial Highlights

Profitability

Gross Margin i N/A

Operating Margin i 87.17%

Profit Margin i 74.09%

Returns and Earnings

Return on Assets (TTM) i -0.32%

Return on Equity (TTM) i -0.32%

EBITDA i INR0

Net Income (TTM) i INR12.1M

Growth

Revenue (TTM) i

Revenue Per Share (TTM) i INR0.03

Quarterly Revenue Growth (YoY) i N/A

Quarterly Earnings Growth (YoY) i -100.00%

Peer Performance Comparison

Performance comparison table showing returns for peer companies over various time periods
Company	Market Cap	1W	1M	3M	6M	YTD	1Y	3Y	5Y
Biogen Pharmachem BIOGEN	830.39M Small-cap	3.41%	-2.15%	-10.78%	-11.65%	-22.88%	-31.06%	-3.19%	127.50%
Motilal Oswal MOTILALOFS	557.10B Large-cap	-0.94%	-0.61%	17.76%	54.28%	-4.25%	33.43%	20.54%	29.94%
Authum Investment AIIL	506.66B Large-cap	0.53%	3.29%	35.53%	98.76%	58.12%	73.41%	249.27%	249.27%
Share India SHAREINDIA	33.23B Small-cap	-4.82%	-12.67%	-10.99%	-27.67%	-49.22%	-48.15%	-33.45%	633.03%
Shalimar Agencies SAGL	26.99B Small-cap	-7.71%	-4.31%	94.71%	199.18%	280.86%	691.52%	946.26%	3,038.79%
Monarch Networth MONARCH	26.25B Small-cap	1.20%	-13.00%	6.23%	-4.58%	-23.81%	-19.29%	87.18%	286.90%

Ownership & Short Interest

Insider Ownership i 41.00%

Institutional Ownership i 0.00%

Shares Short i N/A

Short Ratio i N/A

Short % of Shares Outstanding i N/A

Average 10-Day Volume i 654K

Average 90-Day Volume i 1M

Biogen Pharmachem Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in Biogen Pharmachem would have performed over time.

Calculator Requires JavaScript

The investment calculator requires JavaScript to perform real-time calculations. Please enable JavaScript for the full experience.

Alternative: Manual Calculation

For historical performance data of Biogen Pharmachem, please visit the price history page to analyze returns manually.

Recent Performance Summary:

1 Week: 3.41%
1 Month: -2.15%
3 Months: -10.78%
1 Year: -31.06%

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

What is BIOGEN's 52-week high and low?

In the last 52 weeks, Biogen Pharmachem reached a high of ₹1.45 (on August 29, 2024) and a low of ₹0.75 (on May 9, 2025).

What is the market cap and P/E ratio for BIOGEN?

Curious about Biogen Pharmachem's size and valuation? Its market capitalization stands at 830.39M. When it comes to valuation, the P/E ratio (trailing twelve months) is 92.00, and the forward P/E (looking ahead) is N/A.

Does BIOGEN pay dividends? If so, what's the yield?

As for dividends, Biogen Pharmachem isn't currently offering a significant yield, or that specific data isn't available right now.

Who are Biogen Pharmachem's main competitors or similar companies to consider before investing?

When looking at Biogen Pharmachem, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

Company	Mkt Cap	Sector	Industry	1Y Return	3Y Return
Motilal Oswal MOTILALOFS	557.10B	Financial Services	Capital Markets	33.43%	20.54%
Authum Investment AIIL	506.66B	Financial Services	Capital Markets	73.41%	249.27%
Share India SHAREINDIA	33.23B	Financial Services	Capital Markets	-48.15%	-33.45%
Shalimar Agencies SAGL	26.99B	Financial Services	Capital Markets	691.52%	946.26%
Monarch Networth MONARCH	26.25B	Financial Services	Capital Markets	-19.29%	87.18%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

What are the key financial health indicators for Biogen Pharmachem Industries Inc.? (e.g., ROE, Debt/Equity)

To get a sense of Biogen Pharmachem's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -0.32%, the Debt to Equity ratio from the most recent quarter is 0.00, and its Gross Profit Margin stands at N/A.

What is the recent revenue and earnings growth for BIOGEN?

Looking at Biogen Pharmachem's growth, its revenue over the trailing twelve months (TTM) was INR16M. Compared to the same quarter last year (YoY), quarterly revenue grew by N/A, and quarterly earnings saw a YoY growth of -100.00%.

How much of BIOGEN stock is held by insiders and institutions?

Wondering who owns Biogen Pharmachem stock? Company insiders (like executives and directors) hold about 41.00% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.